Results: 39
Reply to correspondence: "The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark".
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2897, doi. 10.1111/all.16312
- By:
- Publication type:
- Article
Interleukin‐5 as a pleiotropic cytokine orchestrating airway type 2 inflammation: Effects on and beyond eosinophils.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2662, doi. 10.1111/all.16303
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2583, doi. 10.1111/all.16288
- Publication type:
- Article
Indirect case‐matched comparison of anti‐IL4Rα versus anti‐IL5Rα on airway hyperresponsiveness.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2873, doi. 10.1111/all.16283
- By:
- Publication type:
- Article
Evaluation of dupilumab on the disease burden in children and adolescents with atopic dermatitis: A population‐based cohort study.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2748, doi. 10.1111/all.16265
- By:
- Publication type:
- Article
Two‐year post‐treatment outcomes following peanut oral immunotherapy in the Probiotic and Peanut Oral Immunotherapy‐003 Long‐Term (PPOIT‐003LT) study.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2759, doi. 10.1111/all.16262
- By:
- Publication type:
- Article
IgE glycosylation and impact on structure and function: A systematic review.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2625, doi. 10.1111/all.16259
- By:
- Publication type:
- Article
IL‐10‐modulated dendritic cells from birch pollen‐ and hazelnut‐allergic patients facilitate Treg‐mediated allergen‐specific and cross‐reactive tolerance.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2826, doi. 10.1111/all.16255
- By:
- Publication type:
- Article
Key factors that influence quality of life in patients with IgE‐mediated food allergy vary by age.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2812, doi. 10.1111/all.16253
- By:
- Publication type:
- Article
From allergy to oncology: Targeting IL‐4 to boost cancer immunotherapy.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2890, doi. 10.1111/all.16251
- By:
- Publication type:
- Article
Effects of dupilumab on quality of life burden in refractory type 2 high unified airway disease.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2871, doi. 10.1111/all.16249
- By:
- Publication type:
- Article
Navigating the evolving landscape of atopic dermatitis: Challenges and future opportunities: The 4th Davos declaration.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2605, doi. 10.1111/all.16247
- By:
- Publication type:
- Article
Therapeutic relevance of eosinophilic inflammation and airway viral interactions in severe asthma.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2589, doi. 10.1111/all.16242
- By:
- Publication type:
- Article
Clinical efficacy of tezepelumab in pre‐selected non‐type 2 asthma patients.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2867, doi. 10.1111/all.16237
- By:
- Publication type:
- Article
Alpine altitude climate treatment improves asthma control, irrespective of biologics use.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2864, doi. 10.1111/all.16233
- By:
- Publication type:
- Article
Evolution of pathologic B‐cell subsets and serum environment‐specific sIgEs in patients with atopic dermatitis and controls, from infancy to adulthood.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2732, doi. 10.1111/all.16225
- By:
- Publication type:
- Article
Correspondence: "The impact of indoor pollution on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma".
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2899, doi. 10.1111/all.16224
- By:
- Publication type:
- Article
Evaluation of dupilumab and benralizumab on peripheral airway resistance and reactance.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2862, doi. 10.1111/all.16214
- By:
- Publication type:
- Article
Children with eosinophilic esophagitis non‐responsive to combination therapy have distinct esophageal transcriptomic and microbiome profile.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2798, doi. 10.1111/all.16208
- By:
- Publication type:
- Article
Global availability and uptake of psychological services for adults, caregivers and children with food allergy.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2787, doi. 10.1111/all.16204
- By:
- Publication type:
- Article
Reply to correspondence: Correspondence to "The impact of indoor pollution on asthma‐related outcomes: A systematic review for the EAACI guidelines on environmental science for allergic diseases and asthma".
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2901, doi. 10.1111/all.16195
- By:
- Publication type:
- Article
Biomarkers of peanut allergy in children over time.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2775, doi. 10.1111/all.16193
- By:
- Publication type:
- Article
Dupilumab efficacy across serum IgE and blood eosinophil levels in chronic rhinosinusitis with nasal polyposis.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2858, doi. 10.1111/all.16189
- By:
- Publication type:
- Article
Allergic inflammation triggers dyslipidemia via IgG signalling.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2680, doi. 10.1111/all.16187
- By:
- Publication type:
- Article
Childhood infections, asthma and allergy trajectories, and chronic rhinosinusitis in middle age: A prospective cohort study across six decades.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2717, doi. 10.1111/all.16184
- By:
- Publication type:
- Article
Real‐world biologics response and super‐response in the International Severe Asthma Registry cohort.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2700, doi. 10.1111/all.16178
- By:
- Publication type:
- Article
Comparison of upper and lower airway expression of SARS‐CoV‐2 receptors in allergic asthma.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2856, doi. 10.1111/all.16157
- By:
- Publication type:
- Article
Succinate induces a Th2 environment in the small intestine but does not exacerbate food allergy.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2853, doi. 10.1111/all.16155
- By:
- Publication type:
- Article
Clinical and molecular response to dupilumab treatment in pediatric atopic dermatitis: Results of the German TREATkids registry.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2849, doi. 10.1111/all.16147
- By:
- Publication type:
- Article
The use of omalizumab in food allergy.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2888, doi. 10.1111/all.16145
- By:
- Publication type:
- Article
Association between Apgar scores within normal range and development of asthma, allergic rhinitis and eczema in childhood: A Danish nationwide register study.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2847, doi. 10.1111/all.16143
- By:
- Publication type:
- Article
Medical algorithm: Diagnosis and management of adult food protein‐induced enterocolitis syndrome.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2881, doi. 10.1111/all.16142
- By:
- Publication type:
- Article
Correspondence: "The effectiveness of pollen allergen immunotherapy on allergic rhinitis over 18 years: A national cohort study in Denmark".
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2895, doi. 10.1111/all.16140
- By:
- Publication type:
- Article
Medical algorithm: Diagnosis and treatment of drug reaction with eosinophilia and systemic symptoms in adult patients.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2876, doi. 10.1111/all.16122
- By:
- Publication type:
- Article
Reply to corresponcence: "Oral immunotherapy in alpha‐gal red meat allergy: Could specific IgE be a potential biomarker in monitoring management?".
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2893, doi. 10.1111/all.16137
- By:
- Publication type:
- Article
Importance of SREBP signaling in controlling lipid metabolism and homeostasis in B cells for future vaccine design.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2885, doi. 10.1111/all.16134
- By:
- Publication type:
- Article
Response of sputum periostin to anti‐T2 biologics treatment in severe asthma.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2842, doi. 10.1111/all.16131
- By:
- Publication type:
- Article
Efficacy and safety of a 7‐week immunotherapy protocol with aluminium hydroxide adsorbed hymenoptera venom.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2840, doi. 10.1111/all.16128
- By:
- Publication type:
- Article
Continuous improvement of FEV<sub>1</sub> in severe eosinophilic asthmatics on anti‐interleukin‐5 therapy.
- Published in:
- Allergy, 2024, v. 79, n. 10, p. 2845, doi. 10.1111/all.16139
- By:
- Publication type:
- Article